| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Broad range monoclonal antibodies ( mAB ) against cytokeratins ( CK ) ( lu 5 , A 45 B / B3 , AE1 / 3 , CAM 5 . 2 ) as well as anti CK 18 ( DC 10 ) and anti CK 19 ( A 53 B / A2 ) were compared with mAB ' s against vimentin , epithelial membrane antigen ( EMA ) , epithelial sialomucin ( ESM 140 C 1 ) , GFAP ( GF 2 ) , neurofilament ( 2F11 ) , Leu 7 ( HNK 1 ) and polyclonal AB ' s against pituitary hormones ( ACTH , FSH , LH , TSH , GH , PRL ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Multicolor immunofluorescence showed beta APP immunoreactivity in type 1 ( GFAP+ A2B5 ) astrocytes , distributed in a fibrillar pattern like that of glial fibrillary acidic protein ( GFAP ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| These hypertrophic astrocytes were found to be GFAP positive but stained weakly for APP . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In these areas , the majority of APP immunoreactive cells were reactive glial fibrillary acidic protein ( GFAP ) positive astrocytes , as shown by double immunofluorescence labeling for GFAP and APP . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| With the exception of glial fibrillary acidic protein ( GFAP ) , beta APP IFAP was not associated with the intermediate filament proteins characteristically found in differentiated cells , i . e . , desmin , the cytokeratins , and neurofilament proteins . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Plaque like lesions and amyloid angiopathy were investigated in the frontal cerebral cortex of four patients with hereditary cerebral hemorrhage with amyloidosis ( Dutch ) ( HCHWA D ) , using immunohistochemical [ antibodies to beta amyloid protein ( A beta ) , beta protein precursor ( beta PP ) , synaptophysin , ubiquitin ( UBQ ) , cathepsin D , paired helical filaments ( PHF ) and glial fibrillary acidic protein ( GFAP ) ] , enzymehistochemical ( acid phosphatase ) and silver [ methenamine silver ( MS ) and Palmgren ] staining methods . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| AD cases with larger numbers of neurofibrillary tangles had higher levels of GFAP transcript ; AD cases with larger numbers of senile plaques had higher levels of APP 695 transcript . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Microcebus cerebral cortex has been investigated using various technics : amyloid beta A 4 protein , alpha 1 antichymotrypsin and ubiquitin immunocytochemistry , thioflavin S staining for amyloid deposition and Bodian ' s silver impregnation not only for amyloid plaques but also for degenerated neurites ; glial fibrillary acidic protein ( GFAP ) immunocytochemistry has been also used for astrocytes . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Increased levels of the KPI containing beta APP and GFAP mRNAs were observed in tissues surrounding areas of neuronal damage . ^^^ A parallel increase of beta APP and GFAP immunoreactivity was observed in reactive astrocytes in these areas . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| A beta 1 40 also altered the number of GFAP immunoreactive astrocytes and ED 1 immunoreactive microglia / macrophages within and around the A beta 1 40 deposit . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| We are currently characterizing these cell lines with respect to expression of APP , T antigen , Nestin , GFAP , NF and Map 2 . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Several hippocampal proteins were unchanged ( GFAP ) or depressed ( beta APP and Mn SOD ) in level , despite elevations in corresponding mRNAs . ^^^ In the aged cohort , hippocampal GFAP mRNA , Mn SOD mRNA , and beta APP emerged as predictors of behavioral impairment , suggesting the involvement of these hippocampal systems in age related cognitive impairment . . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In this study , we have investigated changes in the steady state levels of APP , APO E , and the astrocyte specific marker , glial fibrillary acidic protein ( GFAP ) mRNA in the gerbil hippocampal CA 1 region after a 10 min period of bilateral carotid occlusion induced forebrain ischemia . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| To develop animal models for measuring beta secretase activity in specific brain cells in vivo , we have targeted the expression of the full length human APP to either neurons or astrocytes in transgenic mice using the neuron specific enolase ( NSE ) promoter or a modified glial fibrillary acidic protein ( GFAP ) gene , respectively . ^^^ In contrast , only little beta s APP was detected in brain homogenates of GFAP APP mice , indicating that astrocytes show very little beta secretase activity in vivo . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Using antibodies to ApoE , glial fibrillary acidic protein ( GFAP ) , and A beta , we compared the pattern of immunoreactivity in senile plaques in AD autopsy tissue with that of reactive astrocytes surrounding subacute and old infarcts in both AD and non AD cases . ^^^ We found GFAP and ApoE immunoreactivity , but not A beta label in cell bodies and processes of reactive astrocytes in zones of infarction within cerebral cortex , striatum , and cerebellum , indicating that astrocytes are capable of upregulating ApoE within these 3 regions . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| The most useful tools currently available for detecting axonal damage are antisera to beta APP , PG M 1 , and GFAP , used in conjunction with a routine haematoxylin and eosin stain , but even with immunocytochemistry precise dating of histological changes may not be possible . . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In age matched control ELBW infants , GFAP , TNF alpha , or beta APP positive cells were never found . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| A series of 22 previously diagnosed cases of DAI , with a range of survival times , was studied using immunohistochemistry with antibodies to beta amyloid precursor protein ( beta APP ) , the microglial associated antigen CD 68 ( PG M 1 ) and for GFAP . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| On the other hand , CT 105 did not significantly alter either APP or glial fibrillary acidic protein ( GFAP ) mRNA levels . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| We wished to see what effect rhIL 1ra had on kainic acid induced neuronal death and to investigate how this might relate to changes in expression of the amyloid precursor protein gene ( APP ) and glial fibrillary acid protein ( GFAP ) using in situ hybridization . ^^^ The enhanced neuronal survival in CA 1 , CA 3 and the dorsal thalamus was associated with preservation of APP 695 mRNA ( neuronal form ) and lack of stimulation of APP 770 ( glial form ) and GFAP messages . ^^^ Where there was no neuroprotection APP 695 mRNA was reduced and stimulation of both APP 770 and GFAP mRNAs was observed . ^^^ In conclusion , rhIL 1ra has dose and region dependent effects on neuronal survival after kainic acid and prevents damage induced changes in APP and GFAP mRNAs . . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Therefore , the present investigation examined the effect of two novel brain penetrating pyrrolopyrimidine lipid peroxidation inhibitors ( PNU 101033E and PNU 104067F ) on CA 1 neurodegeneration and the subsequent increase in APP , b AP , APO E , and GFAP immunostaining at 4 days after a 5 minute episode of forebrain ischemia . ^^^ Gerbils were treated at 30 mg / kg orally 30 minutes before the BCO and 2 hours after ischemia , followed by daily dosing for the next day ( microglia and MDA ) and the successive 3 days for APP , b AP , APO E , and GFAP immunostaining . ^^^ APP and APO E staining was significantly suppressed by 50 % and 66 % , respectively , with either compound . b AP immunoreactivity was decreased 56 % with both compounds , and GFAP expression was significantly decreased 53 % ( PNU 101033E ) and 60 . 5 % ( PNU 104067F ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| The Kunitz Protease Inhibitor containing isoform APP 770 KPI+ , the major glial cell isoform , has been shown to be stimulated after KA and was related to neuronal loss and astrocyte activation as gauged by GFAP mRNA . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Also evident in Abeta infused animals was an increase in GFAP immunostaining around cerebral blood vessels , and an enhancement of OX 42 microglial immunostaining in brain white matter . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Doubly transgenic mice ( PSAPP ) overexpressing mutant APP and PS 1 transgenes were examined using antibodies to Abeta subtypes and glial fibrillary acidic protein ( GFAP ) . ^^^ Deposits were associated with prominent gliosis which increased with age , but in 14 month old PSAPP mice , GFAP immunoreactivity in the vicinity of amyloid deposits was substantially reduced compared to APP littermates . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| METHODS : Study material comprised sections from 28 brains showing evidence of cerebral hypoxia with no history of head injury , four with a history of head trauma but no evidence of hypoxic change , eight with a history of head trauma and hypoxic change , and four from control brains originally described as `` diffuse axonal injury . ' ' These were subjected to microwave antigen retrieval and immunohistochemistry using monoclonal antibodies to beta amyloid precursor protein ( beta APP ) , glial fibrillary acid protein ( GFAP ) , and CD 68 PGM1 . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| A beta 42 was associated with a significantly larger area of glial fibrillary acidic protein ( GFAP ) immunoreactivity and a greater density of reactive astrocytes than A beta 40 . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Immunohistochemistry was performed with antibodies directed against AbetaPP , Abeta 40 , Abeta 42 , APbeta 17 24 , Abeta 1 17 and Abeta 8 17 as well as by double labeling with antibodies directed against Abeta 17 24 , Abeta 42 , and glial fibrillary acid protein ( GFAP ) . ^^^ A large number of GFAP positive astrocytes containing N terminal truncated Abeta fragments appeared in the vicinity of N terminal truncated Abeta , whereas Abeta containing astrocytes were rarely seen in the vicinity of full length Abeta . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Densities of Nissl stained neurons and lesions which were immunolabeled for tau , beta amyloid ( Abeta ) , alpha and beta synuclein , ubiquitin , glial fibrillary acidic protein ( GFAP ) and CD 68 antigen were determined using computer assisted , non biased quantitative microscopy . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In addition , A beta 1 42 increased immunoreactivities of the astrocyte marker glial fibrillary acidic protein ( GFAP ) and interleukin 1 beta ( IL 1 beta ) in the hippocampus , effects also suppressed by pretreatment with ferulic acid . 5 . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Anti beta amyloid precursor protein ( APP ) , glial fibrillary acidic protein ( GFAP ) , and ionized calcium binding adaptor molecule 1 ( Iba 1 ) antibodies were used as markers for axonal damage , reactive astrocytes and activated microglia , respectively . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| With low dose but not high dose curcumin treatment , the astrocytic marker GFAP was reduced , and insoluble beta amyloid ( Abeta ) , soluble Abeta , and plaque burden were significantly decreased by 43 50 % . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| The cases were studied with histologic methods and with single and double immunostaining for beta amyloid ( Abeta ) , paired helical filaments tau ( PHF tau ) , neurofilament ( NF ) , glial fibrillary acidic protein ( GFAP ) , HLA DR , and amyloid precursor protein ( APP ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| One injection of 10 microg of anti Abeta antibody into the third ventricle at 10 months completely prevented or restored changes in GFAP at 11 months of age . ^^^ In addition , whereas control injections of saline or IgG produced greatly increased GFAP diffusely in the hippocampus of Tg 2576 animals , there was no increase in GFAP after anti Abeta injection , suggesting a synergistic interaction of nonspecific trauma with Abeta in the transgenic mice . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Administration of Abeta ( 25 35 ) caused reactive gliosis in the ipsilateral hemisphere as demonstrated by upregulation of GFAP expression and the presence of hypertrophic astrocytes in the hippocampus . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Paraffin embedded coronal sections were stained with HE or FJ , or analyzed immunohistochemically for GFAP or amyloid precursor protein ( APP ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Dual labeling immunohistochemistry for Abeta 1 40 with an astrocytic ( GFAP ) or microglial ( CD11b ) marker was performed to examine co localization of Abeta 1 40 and glial markers . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| The bidirectional potential of atypical cells is obvious by their strong GFAP and APP surface staining . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Previously we showed that in Tg 2576 mouse hippocampus , synaptosomal associated protein 25 ( SNAP 25 ) immunoreactivity ( IR ) is greatly reduced and intracerebroventricular injection of anti Abeta reverses this depletion . 3 and 24 month old wild type mice received juxta amygdala injection of Abeta 42 and hippocampal sections were analyzed for glial fibrillary acidic protein ( GFAP ) and SNAP 25 IR at intervals after injections . ^^^ In young mice , the injections of Abeta caused 20 fold increases in GFAP IR in the fimbria / IC and 2 fold increases in the hippocampal neuropil at 1 week , all of which values returned to baseline by 8 weeks . ^^^ In old mice , Abeta injections caused relatively much larger increases in GFAP IR in the hippocampal neuropil than in the fimbria / IC and the GFAP IR remained greatly increased at 8 weeks . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| Abeta 1 42 injection into the rat entorhinal cortex ( EC ) caused the hyperphosphorylation of tau on both sides of EC and hippocampus and increased the number of glial fibrillary acidic protein ( GFAP ) positive astrocytes in the ipsilateral EC , which were prevented by the concurrent injection of Abeta 1 40 . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| To assess the importance of potential confounders TaqMan real time RT PCR was used to measure seven mRNAs ( beta actin , glyceraldehyde 3 phosphate dehydrogenase ( GAPDH ) , cyclophilin , microtubule associated protein ( MAP ) 2 , neuron specific enolase ( NSE ) , glial fibrillary acidic protein ( GFAP ) , amyloid precursor protein ( APP ) isoform 770 ) in cortical samples taken from 90 Alzheimer ' s disease ( AD ) and 81 control brains . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| METHODS : Stereologic assessments of amyloid burden and tangle density as well as ELISA based measurements of Abeta , synaptophysin , and glial fibrillary acidic protein ( GFAP ) were performed in the superior temporal sulcus from a cohort of 83 AD and 26 nondemented control brains . ^^^ RESULTS : Relative to control cases , AD brains were characterized by accumulation of NFT and amyloid plaques , increase of tris and formic acid extractable Abeta species , reduced levels of synaptophysin , and elevated levels of GFAP . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In the present study we examined sections of frontal lobe from 125 autopsy confirmed cases of AD and assessed the relationship of degenerative large and small vessel disease , CAA , parenchymal Abeta load and APOE genotype , to several objective measures of white matter damage : extent of immunolabelling for glial fibrillary acidic protein ( GFAP ) , axonal accumulation of amyloid precursor protein ( APP ) , axon density in superficial and deep white matter , and intensity of staining for myelin . ^^^ However , labelling of white matter for GFAP correlated strongly with the parenchymal Abeta load ( P = 0 . 0003 ) and with APP accumulation ( P = 0 . 008 ) . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| In vitro characterization of this antibody using both a cell free system and a cell model system of apoptosis demonstrated that the antibody ( termed GFAP caspase cleavage product antibody or GFAP CCP Ab ) immunolabeled the predicted caspase cleavage fragment , but not full length GFAP , by Western blot analysis . ^^^ To determine whether caspases cleave GFAP in vivo , tissue sections from control and AD brains were examined by immunohistochemistry using the GFAP CCP Ab . ^^^ Furthermore , co localization of the GFAP CCP Ab and an antibody specific to active caspase 3 was demonstrated within damaged astrocytes of the AD brain . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| STS treatment increased GFAP promoter activity and increased expression and secretion of APP in NT 2 / D1 cell culture . ^^^ Overexpressed APP enhanced GFAP promoter activity and expression of GFAP , while gene silencing of APP by RNA interference decreased GFAP expression . ^^^ Furthermore , suppression of ERK1 / 2 phosphorylation , which is known to regulate APP expression by a MEK 1 inhibitor , PD 098059 , reduced both APP and GFAP expression in STS treated NT 2 / D1 cells . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| We used new software , P MOD , to identify comprehensively and map PTMs using mass spectral data from soluble ( normal ) and detergent insoluble ( pathological ) protein fractions from AD , as well as total extracts from controls , for selected proteins : Abeta , tau , apolipoprotein ( apo ) E , glial fibrillary acidic protein ( GFAP ) , alpha 3 tubulin , and beta 3 tubulin . ^^^ Our results confirmed direct observations of others by identifying methionine ( M ) sulfoxides at Abeta position 35 and numerous sites of tau phosphorylation in detergent insoluble protein from AD , while no PTMs were enriched on primarily astrocyte derived apoE or GFAP in this fraction . ^^^ |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P14136 and P05067 |
Pubmed |
SVM Score :0.0 |
| NA |
|